Very early following vaccinia inoculation, many vaccinia-specific CD4 T cells were also CTL, expressing mainly Granzyme K, at day 14, at the same time as the peak of activated CD4 T cells in blood (10), consistent with what was reported for a COVID-19 patient during the acute phase of the infection (75). This evidence concerns the gene GZMK and COVID-19.